These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 19487160

  • 1. Natural killer and gammadelta T cells in haematological malignancies: enhancing the immune effectors.
    Rey J, Veuillen C, Vey N, Bouabdallah R, Olive D.
    Trends Mol Med; 2009 Jun; 15(6):275-84. PubMed ID: 19487160
    [Abstract] [Full Text] [Related]

  • 2. NK cells: innate immunity against hematological malignancies?
    Costello RT, Fauriat C, Sivori S, Marcenaro E, Olive D.
    Trends Immunol; 2004 Jun; 25(6):328-33. PubMed ID: 15145323
    [Abstract] [Full Text] [Related]

  • 3. Non-steroidal anti-inflammatory drugs selectively inhibit cytokine production by NK cells and gamma delta T cells.
    Inaoka M, Kimishima M, Takahashi R, Shiohara T.
    Exp Dermatol; 2006 Dec; 15(12):981-90. PubMed ID: 17083365
    [Abstract] [Full Text] [Related]

  • 4. IL-15 an immunoregulatory and anti-cancer cytokine. Recent advances.
    Shanmugham LN, Petrarca C, Frydas S, Donelan J, Castellani ML, Boucher W, Madhappan B, Tete' S, Falasca K, Conti P, Vecchiet J.
    J Exp Clin Cancer Res; 2006 Dec; 25(4):529-36. PubMed ID: 17310844
    [Abstract] [Full Text] [Related]

  • 5. Innate immune-mediated neuronal injury consequent to loss of astrocytes.
    Darlington PJ, Podjaski C, Horn KE, Costantino S, Blain M, Saikali P, Chen Z, Baker KA, Newcombe J, Freedman M, Wiseman PW, Bar-Or A, Kennedy TE, Antel JP.
    J Neuropathol Exp Neurol; 2008 Jun; 67(6):590-9. PubMed ID: 18520777
    [Abstract] [Full Text] [Related]

  • 6. Alternative cytotoxic effector mechanisms in infections with immunodeficiency viruses: gammadelta T lymphocytes and natural killer cells.
    Malkovsky M, Wallace M, Fournié JJ, Fisch P, Poccia F, Gougeon ML.
    AIDS; 2000 Jun; 14 Suppl 3():S175-86. PubMed ID: 11086860
    [No Abstract] [Full Text] [Related]

  • 7. [NKT cell-mediated immunotherapy for hematological malignancies].
    Fujii S.
    Rinsho Ketsueki; 2007 Mar; 48(3):188-99. PubMed ID: 17441475
    [No Abstract] [Full Text] [Related]

  • 8. Structural immunology and crystallography help immunologists see the immune system in action: how T and NK cells touch their ligands.
    Chen Y, Shi Y, Cheng H, An YQ, Gao GF.
    IUBMB Life; 2009 Jun; 61(6):579-90. PubMed ID: 19472182
    [Abstract] [Full Text] [Related]

  • 9. Natural killer cells and malignant haemopathies: a model for the interaction of cancer with innate immunity.
    Sanchez CJ, Le Treut T, Boehrer A, Knoblauch B, Imbert J, Olive D, Costello RT.
    Cancer Immunol Immunother; 2011 Jan; 60(1):1-13. PubMed ID: 20697893
    [Abstract] [Full Text] [Related]

  • 10. [Natural cellular immunity as the effector mechanism in tumor defense].
    Zielinski C, Müller C.
    Acta Med Austriaca; 1987 Jan; 14(2):34-6. PubMed ID: 3630578
    [Abstract] [Full Text] [Related]

  • 11. Can NK cells be a therapeutic target in human cancer?
    Chan CJ, Andrews DM, Smyth MJ.
    Eur J Immunol; 2008 Nov; 38(11):2964-8. PubMed ID: 18979512
    [Abstract] [Full Text] [Related]

  • 12. Killers and beyond: NK-cell-mediated control of immune responses.
    Andoniou CE, Coudert JD, Degli-Esposti MA.
    Eur J Immunol; 2008 Nov; 38(11):2938-42. PubMed ID: 18979519
    [Abstract] [Full Text] [Related]

  • 13. Cancer Immunotherapy by coordinated stimulation of innate lymphocytes (NK and NKT cells).
    Fujii S.
    Rinsho Ketsueki; 2009 May; 50(5):364-74. PubMed ID: 19483396
    [No Abstract] [Full Text] [Related]

  • 14. Functions of natural killer cells.
    Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S.
    Nat Immunol; 2008 May; 9(5):503-10. PubMed ID: 18425107
    [Abstract] [Full Text] [Related]

  • 15. [Effect of chemotherapy on anticancer immune effector cells].
    Saijo N.
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):699-707. PubMed ID: 6410999
    [Abstract] [Full Text] [Related]

  • 16. [Immunology and tumors. Effector cells].
    Sebastiani M, Cosma AM, Ferri AM.
    Arch Sci Med (Torino); 1980 Mar; 137(2):277-88. PubMed ID: 6971636
    [Abstract] [Full Text] [Related]

  • 17. NK cell-based cancer immunotherapy.
    Stagg J, Smyth MJ.
    Drug News Perspect; 2007 Apr; 20(3):155-63. PubMed ID: 17520092
    [Abstract] [Full Text] [Related]

  • 18. Innate immunity and hypersensitivity syndrome.
    Inaoka M.
    Toxicology; 2005 Apr 15; 209(2):161-3. PubMed ID: 15767029
    [Abstract] [Full Text] [Related]

  • 19. Natural killer cells in human autoimmunity.
    Flodström-Tullberg M, Bryceson YT, Shi FD, Höglund P, Ljunggren HG.
    Curr Opin Immunol; 2009 Dec 15; 21(6):634-40. PubMed ID: 19892538
    [Abstract] [Full Text] [Related]

  • 20. NK and NKT cells in liver injury and fibrosis.
    Notas G, Kisseleva T, Brenner D.
    Clin Immunol; 2009 Jan 15; 130(1):16-26. PubMed ID: 18823822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.